Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Mojsov as the 2026 Kimberly Prize winner for her pioneering discoveries and contributions on GLP-1
Mounjaro's sales dip: How cheap generics are redrawing India's GLP-1 market The arrival of cheaper semaglutide alternatives signals that the Indian obesity drug market has moved from a launch-led boom into something more structurally competitive Eli Lilly's Mounjaro posted its first monthly sales drop in India in Marcha Rs 20-crore decline, from roughly Rs 135 crore in February to Rs 114 crorejust days after a clutch of Indian generics entered the country's booming GLP-1 market
References Lillys oral GLP-1, orforglipron, superior to oral semaglutide in head-to-head trial
The good news is that making this change is relatively easy to do
The mental chatter quiets
The lightweight essence absorbs quickly, leaving skin refreshed, hydrated, and visibly more radiant
